Thrombosis
Conference Coverage
Apixaban for VTE reduced subsequent hospitalizations
Major finding: Patients whose acute venous thromboembolism was treated with 6 months of apixaban were 21% less likely to have another...
News
INR test strips recalled due to reports of inaccurate results
Conference Coverage
Rivaroxaban replacing warfarin for AF stroke protection
Major finding: Rivaroxaban use grew from approximately 8% of AF patients in 2011 to 16% in 2012 and 30% in 2013.Data source: Review of...
News
Mortality nearly halved with dual antiplatelet therapy in severe PAD
Major finding: Patients with severe peripheral artery disease who were on dual antiplatelet therapy had an adjusted 45% reduction in the 3-year...
Conference Coverage
Despite VTE prophylaxis, more bleeds, no benefit in medical inpatients
Major finding: As VTE prophylaxis climbed from 59.2% to 77.9% over 2-plus years, the rate of symptomatic VTEs held steady at 0.56%, but major...
Conference Coverage
Apixiban for VTE reduces subsequent hospitalizations
Major finding: Patients whose acute venous thromboembolism was treated with 6 months of apixaban were 21% less likely to have another...
Conference Coverage
Ultrasound-facilitated endovascular thrombolysis 'a game changer' in acute pulmonary embolism
Major finding: Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in patients with high-risk pulmonary embolism improved right...
Conference Coverage
Off-label use of novel anticoagulants accelerates
Major finding: By the fourth quarter of 2012, 14.9% of patients with nonvalvular AF were on a novel anticoagulant. So were 13.8% of those with...
News
Tenecteplase has risks but cuts hemodynamic decompensation in pulmonary embolism
Major finding: The primary efficacy outcome – a composite of death from any cause or hemodynamic (including hemodynamic collapse) within 7 days –...